Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Wiel, B.A. van de
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(17)
+
-
Availability
Open access
(13)
+
-
Metadata Only
(4)
+
-
Creation Date
2021
(7)
+
-
2022
(4)
+
-
2023
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(13)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(13)
+
-
Scholarly Publications
(4)
+
-
Topic
immunotherapy
(3)
+
-
melanoma
(3)
+
-
Immunotherapy
(2)
+
-
Melanoma
(2)
+
-
neoadjuvant
(2)
+
-
Author
Wiel, B.A. van de
(17)
+
-
Blank, C.U.
(12)
+
-
Klop, W.M.C.
(12)
+
-
Akkooi, A.C.J. van
(11)
+
-
Rozeman, E.A.
(10)
+
-
Houdt, W.J. van
(9)
+
-
Long, G.V.
(9)
+
-
Menzies, A.M.
(9)
+
-
Scolyer, R.A.
(9)
+
-
Ch'ng, S.
(8)
+
-
Haanen, J.B.A.G.
(8)
+
-
Saw, R.P.M.
(8)
+
-
Grijpink-Ongering, L.G.
(7)
+
-
Reijers, I.L.M.
(7)
+
-
Sikorska, K.
(7)
+
-
Versluis, J.M.
(7)
+
-
Wouters, M.W.
(7)
+
-
Zuur, C.L.
(7)
+
-
Gonzalez, M.
(6)
+
-
Spillane, A.J.
(6)
+
-
Rawson, R.V.
(5)
+
-
Acosta, A.T.
(4)
+
-
Broeks, A.
(4)
+
-
Hiel, B. van der
(4)
+
-
Kapiteijn, E.
(4)
+
-
Nieweg, O.E.
(4)
+
-
Shannon, K.F.
(4)
+
-
Thienen, J.V. van
(4)
+
-
Bierman, C.
(3)
+
-
Colebatch, A.J.
(3)
+
-
Eriksson, H.
(3)
+
-
Grunhagen, D.J.
(3)
+
-
Hage, J.A. van der
(3)
+
-
Tinteren, H. van
(3)
+
-
Wouters, M.W.J.M.
(3)
+
-
Adriaansz, S.
(2)
+
-
Berg, N.S. van den
(2)
+
-
Boekhout, A.H.
(2)
+
-
Cornelissen, S.
(2)
+
-
Dimitriadis, P.
(2)
+
-
Heuvel, N.M.J. van den
(2)
+
-
Hospers, G.A.P.
(2)
+
-
Jozwiak, K.
(2)
+
-
KleinJan, G.H.
(2)
+
-
Leeuwen, F.W.B. van
(2)
+
-
Lijnsvelt, J.M.
(2)
+
-
Mallo, H.A.
(2)
+
-
Meier, M.A.J.
(2)
+
-
Olmos, R.A.V.
(2)
+
-
Peeper, D.S.
(2)
+
-
Pennington, T.E.
(2)
+
-
Poll-franse, L.V. van de
(2)
+
-
Prevoo, W.
(2)
+
-
Sanders, J.
(2)
+
-
Schilling, B.
(2)
+
-
Schrage, Y.M.
(2)
+
-
Stahlie, E.H.A.
(2)
+
-
Suijkerbuijk, K.P.M.
(2)
+
-
Veldt, A.A.M. van der
(2)
+
-
Witkamp, A.J.
(2)
+
-
Show more
Language
en
(17)
+
-
Search results
(1 - 17 of 17)
show grid
show list
save search
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Technologic (r)evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region
Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection, REDUCTOR
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
Original Research Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes
Combined radiofrequency ablation and ipilimumab in uveal melanoma: Results from the SECIRA-UM trial
Immune-Escape Markers in Relation to Clinical Outcome of Advanced Melanoma Patients Following Immunotherapy